ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Pharmaceutical and Biotech Industries Training Course | Master Drug Development from Discovery to Marketing in Just One Day (ONLINE EVENT: September 22, 2025) - ResearchAndMarkets.com

The "An Essential Overview of the Pharmaceutical and Biotech Industries Training Course" training has been added to ResearchAndMarkets.com's offering.

The pharmaceutical and biotechnology industries are both complex and developing at a rapid pace. This intensive one-day course will give you an invaluable overview, refresher and update on all the important aspects from discovery of the molecule through development to marketing. The interactive programme will provide a step-by-step understanding of the main areas of drug development and will discuss the roles and responsibilities of key departments and how they work and interact together.

There will be interactive discussion sessions throughout the day, led by our expert course leader, and you will come away with a good knowledge of the structure and function of these industries.

Why you should attend

  • Increase your understanding of the pharma/biotech industries
  • Develop your knowledge of the stages of drug development from drug discovery through to marketing
  • Get to grips with the phases of clinical trials, regulatory processes and pharmacovigilance requirements
  • Understand the roles and responsibilities of key departments and how they work together
  • Demystify the technical terminology and jargon

Certification:

  • CPD: 6 hours for your records
  • Certificate of completion

Who Should Attend:

This event will be of interest to all those looking to develop their knowledge of how the pharmaceutical and biotechnology industries work. It will be particularly helpful for those wanting to understand what other departments do, for new staff working in the industry and for non-scientific and administrative personnel.

Key Topics Covered:

How the Pharma/Biotech Industries Develop Medicines

  • Overview of drug development
  • Framework of the industry - research, development and manufacture of pharma products on an international level
  • Difference between pharma and biotech drug development
  • Drug discovery
  • Non-clinical/pre-clinical - the importance of examining safety
  • Technologies and innovations across the industry

Demystifying the Jargon and Terminology

Roles and Responsibilities of the People in the Pharma/Biotech Industries

Clinical Trials

  • Phases of clinical research - phase 1 to Phase IV and range of clinical trials
  • Setting up and running of clinical trials
  • Quality of the data - monitoring, auditing and compliance with GCP innovations in running clinical trials

Pharmacovigilance

  • Understanding safety reporting and signal detection
  • Definitions and periodic and drug safety update reports

Regulatory Processes

  • Overview of regulatory submissions and approval procedures for pharma/biotech products including EU and FDA procedures
  • The importance of ICH including the electronic Common Technical Document (eCTD)
  • The EU Clinical Trial Regulation

Commercial Considerations for How Medicines are Marketed and Sold

  • Marketing terminology and activities

For more information about this training visit https://www.researchandmarkets.com/r/eqxo6z

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.